These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2228218)

  • 21. B cell mitogenic properties of thymus-independent antigens.
    Coutinho A; Möller G
    Nat New Biol; 1973 Sep; 245(140):12-4. PubMed ID: 4125593
    [No Abstract]   [Full Text] [Related]  

  • 22. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens.
    Vinuesa CG; Sze DM; Cook MC; Toellner KM; Klaus GG; Ball J; MacLennan IC
    Eur J Immunol; 2003 Feb; 33(2):297-305. PubMed ID: 12548560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of humoral immune responses to a thymic-independent antigen in mice immunosuppressed by a graft-versus-host reaction.
    Treiber W; Lapp WS
    Cell Immunol; 1978 Apr; 37(1):118-26. PubMed ID: 26470
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.
    Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B
    Rev Infect Dis; 1981; 3(2):332-41. PubMed ID: 6973183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses in nonhaired mice.
    Smith SM; Forbes PD; Linna TJ
    Int Arch Allergy Appl Immunol; 1982; 67(3):254-61. PubMed ID: 6977495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.
    Kuijpers TW; Weening RS; Out TA
    Allergol Immunopathol (Madr); 1992; 20(1):28-34. PubMed ID: 1509985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant actions of polyclonal lymphocyte activators. II. Comparison and characterization of their actions in initiation and potentiation of immune responses to T-dependent and T-independent soluble antigens.
    Nakashima I; Nagase F; Matsuura A; Kato N
    Cell Immunol; 1980 Feb; 49(2):360-71. PubMed ID: 6153295
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody responses against pneumococcal polysaccharide antigens in vaccinated persons.
    Leinonen M
    Ann Clin Res; 1982 Dec; 14(5-6):267-71. PubMed ID: 7171234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract]   [Full Text] [Related]  

  • 30. Requirements for activation of contrasuppressor T cells by type III pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1986 Jan; 136(2):396-401. PubMed ID: 2867113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for B cells for activation of contrasuppressor T cells by type III pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1990 Apr; 144(7):2465-72. PubMed ID: 2319128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of gonococcal Gc2 polysaccharide: comparative studies with pneumococcal type III polysaccharide and Salmonella typhosa Vi antigen.
    Breen JF; Apicella MA
    Infect Immun; 1978 Oct; 22(1):195-9. PubMed ID: 32136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response.
    Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolysin-producing Listeria monocytogenes affects the immune response to T-cell-dependent and T-cell-independent antigens.
    Hage-Chahine CM; Del Giudice G; Lambert PH; Pechere JC
    Infect Immun; 1992 Apr; 60(4):1415-21. PubMed ID: 1548067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against encapsulated bacteria in humans: paradoxes.
    Weller S; Reynaud CA; Weill JC
    Trends Immunol; 2005 Feb; 26(2):85-9. PubMed ID: 15668123
    [No Abstract]   [Full Text] [Related]  

  • 36. Low dose unresponsiveness with a thymus independent antigen.
    Waldmann H; Pope H
    Nature; 1975 Dec; 258(5537):730-1. PubMed ID: 1082099
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro antibody response of primed rabbit peripheral blood lymphocytes to group A variant streptococcal polysaccharide.
    Read SE; Braun DG
    Eur J Immunol; 1974 Jun; 4(6):422-6. PubMed ID: 4606658
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
    Baker CJ; Rench MA; Kasper DL
    N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of the antibody response to type III pneumococcal polysaccharide with antigen coupled to syngeneic lymphoid cells.
    Braley-Mullen H
    Cell Immunol; 1980 Jun; 52(1):132-9. PubMed ID: 6156010
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.
    Ekwunife FS; Taylor CE; Fauntleroy MB; Stashak PW; Baker PJ
    Infect Immun; 1991 Jun; 59(6):2192-4. PubMed ID: 1828058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.